Tezeo

Leaflet accompanying the packaging: patient information

Warning! Keep the leaflet! Information on the immediate packaging in a foreign language.

Tezeo

80 mg, tablets

Telmisartanum

Before taking the medicine, carefully read the contents of the leaflet, as it contains important information for the patient.

• The leaflet should be kept so that it can be re-read if necessary.
• In case of any doubts, the doctor or pharmacist should be consulted.
• This medicine has been prescribed to a specific person. It should not be given to others. The medicine may harm another person, even if the symptoms of their illness are the same.
• If the patient experiences any side effects, including any possible side effects not listed in this leaflet, they should inform their doctor or pharmacist. See section 4.

Table of contents of the leaflet

• 1. What is Tezeo and what is it used for
• 2. Important information before taking Tezeo
• 3. How to take Tezeo
• 4. Possible side effects
• 5. How to store Tezeo
• 6. Contents of the packaging and other information

1. What is Tezeo and what is it used for

Tezeo belongs to a group of medicines called angiotensin II receptor antagonists.
Angiotensin II is a substance produced by the body that causes blood vessels to constrict, leading to an increase in blood pressure. Tezeo blocks the action of angiotensin II, causing blood vessels to relax and blood pressure to decrease.
Tezeo is usedto treat essential hypertension (high blood pressure) in adults. Essential means that high blood pressure is not caused by another disease.
Untreated high blood pressure can lead to damage to blood vessels in various organs, which in some cases can lead to heart attack, heart failure, or kidney disease, stroke, or vision loss. Usually, high blood pressure does not cause any symptoms before such disorders occur. Therefore, it is essential to regularly measure blood pressure to determine if its value is within the normal range.
Tezeo is also usedto reduce the frequency of cardiovascular events (such as heart attack or stroke) in adults at risk, i.e., those with reduced blood flow to the heart or legs, who have had a stroke, or who have diabetes.
The doctor will inform the patient if they belong to the risk group for the above disorders.

2. Important information before taking Tezeo

When not to take Tezeo

• if the patient is allergic to telmisartan or any other component of this medicine (listed in section 6)
• after the third month of pregnancy (it is also recommended to avoid taking Tezeo in early pregnancy, see "Pregnancy")
• if the patient has severe liver disorders, such as cholestasis or biliary obstruction (obstruction of bile flow from the liver and gallbladder) or any other severe liver disease
• if the patient has diabetes or kidney problems and is being treated with a blood pressure-lowering medicine containing aliskiren.

If any of the above situations apply to the patient, they should inform their doctor or pharmacist before taking Tezeo.

Warnings and precautions

Before starting to take Tezeo, the patient should discuss it with their doctor or pharmacist. The patient should inform their doctor if they have or have had any of the following conditions or diseases:

• kidney disease or post-kidney transplant
• renal artery stenosis (narrowing of the blood vessels supplying one or both kidneys)
• liver disease
• heart disease
• increased aldosterone levels (water and salt retention in the body, accompanied by mineral imbalance in the blood)
• low blood pressure (hypotension), which is more likely if the patient is dehydrated (excessive water loss from the body) or has a salt deficiency due to: taking diuretics, a low-salt diet, diarrhea, or vomiting
• high potassium levels in the blood
• diabetes.

Before starting to take Tezeo, the patient should inform their doctor:

• if they are taking digoxin
• if they are taking any of the following medicines used to treat high blood pressure:
• angiotensin-converting enzyme inhibitor (ACE inhibitor) (e.g., enalapril, lisinopril, ramipril), especially if the patient has kidney problems related to diabetes.
• aliskiren. The doctor may monitor kidney function, blood pressure, and electrolyte levels (e.g., potassium) in the blood at regular intervals.

See also the information under the heading "When not to take Tezeo".
The patient must inform their doctor if they suspect they are pregnant (or may become pregnant).
It is not recommended to take Tezeo in early pregnancy and it should not be taken after 3 months of pregnancy, as it may be very harmful to the fetus (see "Pregnancy").
In the case of planned surgery or anesthesia, the patient should inform their doctor about taking Tezeo.
Tezeo may be less effective in lowering blood pressure in people of black race.

Children and adolescents

Tezeo should not be used in children and adolescents under 18 years of age.

Tezeo and other medicines

The patient should tell their doctor or pharmacist about all medicines they are taking or have recently taken, as well as any medicines they plan to take. The doctor may decide to change the dose and/or take other precautions. In some cases, it may be necessary to stop taking one of the medicines. This applies especially to the simultaneous use of Tezeo with the following medicines:

• lithium preparations used to treat certain types of depression;
• medicines that can increase potassium levels in the blood, such as potassium substitutes, potassium-sparing diuretics (some diuretics), angiotensin II receptor antagonists, non-steroidal anti-inflammatory drugs (NSAIDs, e.g., acetylsalicylic acid or ibuprofen), heparin, immunosuppressive agents (e.g., cyclosporine or tacrolimus), and the antibiotic trimethoprim.
• diuretics, especially when taken in high doses with Tezeo; as they may lead to significant water loss from the body and a decrease in blood pressure (hypotension);
• ACE inhibitors or aliskiren (used to treat high blood pressure) (see also the information under the heading "When not to take Tezeo" and "Warnings and precautions");
• digoxin.

The effect of Tezeo may be weakened when taking non-steroidal anti-inflammatory drugs (NSAIDs, e.g., acetylsalicylic acid or ibuprofen) or corticosteroids.
Tezeo may enhance the blood pressure-lowering effect of other medicines used to treat high blood pressure or medicines that may cause a decrease in blood pressure (e.g., baclofen, amifostine). Additionally, the following may have an additive effect on lowering blood pressure: alcohol, barbiturates, narcotics, or antidepressants. A symptom of too low blood pressure may be dizziness when standing up. If it is necessary to adjust the dose of other medicines taken with Tezeo, the patient should consult their doctor.

Pregnancy, breastfeeding, and fertility

If the patient is pregnant or breastfeeding, suspects they may be pregnant, or plans to have a child, they should consult their doctor or pharmacist before taking this medicine.
Pregnancy
The patient should inform their doctor about suspected (or planned) pregnancy. The doctor will usually recommend stopping Tezeo before planned pregnancy or immediately after confirming pregnancy and recommend taking another medicine instead of Tezeo. It is not recommended to take Tezeo in early pregnancy and it should not be taken after 3 months of pregnancy, as it may seriously harm the fetus.
Breastfeeding
The patient should inform their doctor about breastfeeding or intending to breastfeed. It is not recommended to take Tezeo during breastfeeding, especially in the case of breastfeeding a newborn or premature baby. The doctor may recommend taking another medicine.

Driving and using machines

Some patients taking Tezeo may experience dizziness or fatigue. If dizziness or fatigue occurs, the patient should not drive vehicles or operate machines.

Tezeo contains sodium and sorbitol (E 420)

This medicinal product contains less than 1 mmol of sodium (23 mg) per tablet, which means the medicine is considered "sodium-free".
Tezeo contains 324.4 mg of sorbitol per tablet.
Sorbitol is a source of fructose. If the patient has previously been diagnosed with intolerance to some sugars or has been diagnosed with hereditary fructose intolerance, a rare genetic disorder in which the patient's body does not break down fructose, they should contact their doctor before taking the medicine.

3. How to take Tezeo

This medicine should always be taken as directed by the doctor or pharmacist. In case of doubts, the patient should consult their doctor or pharmacist.
Tezeo is available in the following strengths: 40 mg, 80 mg.
The recommended dose of Tezeo is one tablet per day. The patient should try to take the tablet at the same time every day. Tezeo can be taken with or without food.
The tablets should be swallowed with water or another non-alcoholic beverage. It is essential to take Tezeo every day, unless the doctor recommends otherwise. If the patient feels that the effect of Tezeo is too strong or too weak, they should consult their doctor or pharmacist.
In the treatment of high blood pressure, the usual dose of Tezeo for most patients is one 40 mg tablet once daily to ensure blood pressure control for 24 hours. However, sometimes the doctor may recommend a lower dose of 20 mg or a higher dose of 80 mg. The 20 mg dose can be obtained by dividing a 40 mg tablet along the score line. Alternatively, the doctor may recommend taking Tezeo with diuretics (e.g., hydrochlorothiazide), which has an additive blood pressure-lowering effect with telmisartan.
To reduce the frequency of cardiovascular events, the usual dose of Tezeo is one 80 mg tablet once daily. At the beginning of treatment with a dose of 80 mg, blood pressure should be frequently monitored.
In patients with liver function disorders, the usual dose should not exceed 40 mg once daily.

Taking a higher dose of Tezeo than recommended

In case of accidental ingestion of too many tablets, the patient should immediately contact their doctor or pharmacist, or go to the emergency department of the nearest hospital.

Missing a dose of Tezeo

If a dose is missed, the patient should take the missed dose as soon as they remember, and then continue taking the medicine as scheduled. If the medicine is not taken on a given day, the patient should take the next dose at the usual time the following day. The patient should not take a double dose to make up for the missed dose.
In case of any further doubts about taking this medicine, the patient should consult their doctor or pharmacist.

4. Possible side effects

Like all medicines, Tezeo can cause side effects, although not everybody gets them.

Some side effects may be serious and require immediate medical attention.

If the patient experiences any of the following symptoms, they should immediately contact their doctor:
sepsis* (often referred to as "blood poisoning", a severe infection with an inflammatory reaction throughout the body), sudden swelling of the skin and mucous membranes (angioedema). These side effects are rare (may occur in up to 1 in 1000 patients), but are extremely serious. In such a case, the patient should stop taking the medicine and immediately contact their doctor. If these symptoms are not treated, they may be fatal.

Possible side effects of Tezeo

Common side effects (may occur in up to 1 in 10 patients):
low blood pressure (hypotension) in patients treated to reduce the frequency of cardiovascular events.
Uncommon side effects (may occur in up to 1 in 100 patients):
urinary tract infections, upper respiratory tract infections (e.g., sore throat, sinusitis, common cold), decreased red blood cell count (anemia), high potassium levels, sleep disturbances, low mood (depression), fainting, dizziness (vertigo), slow heart rate (bradycardia), low blood pressure (hypotension) in patients treated for high blood pressure, dizziness when standing up (orthostatic hypotension), shortness of breath, cough, abdominal pain, diarrhea, abdominal discomfort, bloating, vomiting, itching, excessive sweating, rash, back pain, muscle spasms, muscle pain (myalgia), kidney function disorders, including acute kidney failure, chest pain, feeling of weakness, and increased creatinine levels in the blood.
Rare side effects (may occur in up to 1 in 1000 patients):
increased white blood cell count (eosinophilia), low platelet count (thrombocytopenia), severe allergic reaction (anaphylactic reaction), allergic reactions (e.g., rash, itching, difficulty breathing, wheezing, facial swelling, or low blood pressure), low blood sugar levels (in patients with diabetes), feeling of restlessness, drowsiness, vision disturbances, rapid heart rate (tachycardia), dry mouth, gastritis, taste disturbances, liver function disorders (more common in patients of Japanese origin), sudden swelling of the skin and mucous membranes, which can also lead to death (angioedema also resulting in death), skin rash, skin redness, hives, severe drug rash, joint pain, limb pain, tendon pain, flu-like symptoms, decreased hemoglobin levels, increased uric acid levels, increased liver enzyme activity or creatine phosphokinase in the blood.
Very rare side effects (may occur in up to 1 in 10,000 patients):
progressive scarring of lung tissue (interstitial lung disease)**
* The event may be coincidental or related to an unknown mechanism.
** There have been reports of progressive scarring of lung tissue during treatment with telmisartan. However, it has not been established whether this is caused by telmisartan.

Reporting side effects

If the patient experiences any side effects, including any possible side effects not listed in this leaflet, they should inform their doctor or pharmacist. Side effects can be reported directly to the Department of Adverse Reaction Monitoring of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: +48 22 49 21 301, fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl.
By reporting side effects, more information can be gathered on the safety of the medicine.

5. How to store Tezeo

The medicine should be stored out of sight and reach of children.
Do not use this medicine after the expiry date stated on the packaging. The expiry date refers to the last day of the month.
Store in a temperature below 30°C.
Store in the original packaging to protect from moisture.
The Tezeo tablet should be removed from the blister pack immediately before use.
Medicines should not be disposed of via wastewater or household waste. The patient should ask their pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.

6. Contents of the packaging and other information

What Tezeo contains

The active substance of Tezeo is telmisartan. Each tablet contains 80 mg of telmisartan.
The other ingredients are: meglumine, sorbitol (E 420), sodium hydroxide, povidone K 25, magnesium stearate.

What Tezeo looks like and contents of the packaging

Tezeois a white to yellowish, with an imprint of "80" on one side, elongated, biconvex tablet, approximately 16 mm long, 8 mm wide, and 4.2-4.8 mm thick.
Pack sizes: 28, 56 tablets.
For more detailed information, the patient should contact the marketing authorization holder or parallel importer.

Marketing authorization holder in the Czech Republic, the country of export:

Zentiva, k. s.
U Kabelovny 130
102 37 Prague 10
Czech Republic

Manufacturer:

Zentiva, k. s.
U Kabelovny 130
102 37 Prague 10
Czech Republic
S.C. Zentiva S.A.
B-dul. Theodor Pallady nr. 50, sector 3
Bucharest
Romania

Parallel importer:

InPharm Sp. z o.o.
ul. Strumykowa 28/11
03-138 Warsaw

Repackaged by:

InPharm Sp. z o.o. Services sp. k.
ul. Chełmżyńska 249
04-458 Warsaw
Marketing authorization number in the Czech Republic, the country of export:58/312/10-C
Parallel import authorization number:31/20

Date of leaflet approval: 24.01.2025

[Information about the trademark]